Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Vaccinex market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Vaccinex's market cap was $2.68M on Oct 19, 2026, against $1.69M a year earlier. Over the last 5 years it ranged from $1.34M to $73.92M, with a median of $7.86M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $2.68M | -7.0% |
| 2025 | Dec 31, 2025 | $2.88M | +13.0% |
| 2024 | Dec 31, 2024 | $2.55M | -20.5% |
| 2023 | Dec 29, 2023 | $3.21M | -88.3% |
| 2022 | Dec 30, 2022 | $27.30M | -14.8% |
| 2021 | Dec 31, 2021 | $32.03M | -30.9% |
| 2020 | Dec 31, 2020 | $46.33M | -16.8% |
| 2019 | Dec 31, 2019 | $55.68M | +33.3% |
| 2018 | Dec 31, 2018 | $41.77M | – |
See a number that looks wrong?